Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) 3-Year Revenue Growth Rate : 5.50% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co 3-Year Revenue Growth Rate?

Shijiazhuang Yiling Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2024 was ¥1.51.

During the past 12 months, Shijiazhuang Yiling Pharmaceutical Co's average Revenue per Share Growth Rate was -35.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 19.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 17.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Shijiazhuang Yiling Pharmaceutical Co was 29.40% per year. The lowest was -7.40% per year. And the median was 13.00% per year.

Competitive Comparison of Shijiazhuang Yiling Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shijiazhuang Yiling Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shijiazhuang Yiling Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shijiazhuang Yiling Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Shijiazhuang Yiling Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.

Shijiazhuang Yiling Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Shijiazhuang Yiling Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

N/A

Address

No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN

Website

http://www.yiling.cn/

Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.

Executives

Zhang Qiu Lian	Directors, executives
Han Yue Zhi	Executives
Zhao Shao Hua	Executives
Wang Wei	Executives
Gao Xue Dong	Supervisors
Wu Yi Ling	Director
Gao Xiu Qiang	Executives
Wu Xiang Jun	Directors, executives
Guo Shuang Geng	Director
Wang Hua	Securities Affairs Representative
Dai Feng Xiang	Directors, executives
Liu Gen Wu	Supervisors
Wang Wei Ping	Directors, executives
Xu Wei Dong	Director
Wu Rui	Directors, executives

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines